Allosteric serotonin reuptake inhibitor
- Allosteric serotonin reuptake inhibitor
Allosteric serotonin reuptake inhibitor is a marketing classification invented by the pharmaceutical company Lundbeck for its selective serotonin reuptake inhibitor (SSRI) escitalopram, the "S" stereoisomer of the SSRI citalopram. It is based on the observation that the "R" isomer of citalopram can decrease the potency and inhibit the effects of the "S" isomer, probably through an allosteric interaction between two distinct, non-overlapping binding sites for the two different isomers on the serotonin transporter.
The term "allosteric" refers to the negative interaction between the binding sites of to different drugs or isomers, however, it does not relate to the action of one drug to the inhibition of serotonin uptake. Allosteric serotonin reuptake inhibitors are therefore not a therapeutically distinct class of SSRI.
References
*cite journal
title = The Pharmacology of Citalopram Enantiomers: The Antagonism by R-Citalopram on the Effect of S-Citalopram
author = Connie Sánchez
journal = Basic & Clinical Pharmacology & Toxicology
year = 2006
volume = 99
issue = 2
pages = 91
doi = 10.1111/j.1742-7843.2006.pto_295.x
Wikimedia Foundation.
2010.
Look at other dictionaries:
Serotonin–norepinephrine reuptake inhibitor — Serotonin No … Wikipedia
Reuptake inhibitor — Escitalopram, a selective serotonin reuptake inhibitor (SSRI) used as an antidepressant. A reuptake inhibitor (RI), also known as a transporter blocker, is a drug that inhibits the plasmalemmal transporter mediated reuptake of a neurotransmitter… … Wikipedia
Norepinephrine-dopamine reuptake inhibitor — Norepinephrine Dopamine … Wikipedia
Norepinephrine reuptake inhibitor — Norepinephrine … Wikipedia
Dopamine reuptake inhibitor — Dopamine A dopamine reuptake inhibitor (DRI, DARI) is a type of drug that acts as a reuptake inhibitor for the neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). This in turn leads to increased extracellular… … Wikipedia
Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… … Wikipedia
Negative allosteric modulator — A negative allosteric modulator (NAM) is a drug which decreases the activity of a receptor indirectly via disactivation of an allosteric site on the protein. NAMs are similar to inverse agonists in that they conteract overall receptor activation … Wikipedia
Discovery and development of dual serotonin and norepinephrine reuptake inhibitors — Serotonin–norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant drugs used in the treatment of major depressive disorder (MDD). SNRIs are potent inhibitors of serotonin (5 Hydroxytryptamine, 5 HT) and norepinephrine (NE,… … Wikipedia
Nicotinic agonist — A nicotinic agonist is a drug which enhances the action at the nicotinic acetylcholine receptor (nAChR). Examples include: nicotine (by definition the nicotinic acetylcholine receptor is named for its affinity for nicotine) acetylcholine, the… … Wikipedia
Receptor antagonist — This article is about the biochemistry term. For other uses, see Antagonist (disambiguation). Antagonists will block the binding of an agonist at a receptor molecule, inhibiting the signal produced by a receptor agonist coupling. A receptor… … Wikipedia
